Lewy Bodies Contain Altered α-Synuclein in Brains of Many Familial Alzheimer's Disease Patients with Mutations in Presenilin and Amyloid Precursor Protein Genes
Carol F. Lippa(Allegheny College), John Q. Trojanowski(University of Pennsylvania), Bernardino Ghetti(Indiana University School of Medicine), David Nochlin(University of Washington), Virginia M.‐Y. Lee(Institute for Neurodegenerative Disorders), Peter St George‐Hyslop(University of Cambridge), David M. A. Mann(Salford Royal NHS Foundation Trust), Nigel J. Cairns(Washington University in St. Louis), Takeshi Iwatsubo(National Center of Neurology and Psychiatry), Minami Baba(The University of Tokyo), Marie L. Schmidt(University of Pennsylvania), Dan A. Pollen(University of Massachusetts Chan Medical School), Brendan P. O’Connell(Cornell University), Hideo Fujiwara(The University of Tokyo), Benoit I. Giasson(University of Florida), Thomas D. Bird(University of Washington), Linda E. Nee(National Institute of Neurological Disorders and Stroke)
Cited by 535
Related Papers
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Lecanemab in Early Alzheimer’s Disease
|New England Journal of Medicine|2022|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k